Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Biyang Cao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5070275017. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: 2 papers · 2025: 3 papers · 2026: 1 paper

Papers 11

  1. Corrigendum to "Long-Term outcomes of ablative stereotactic body radiation therapy for inoperable, non-metastatic pancreatic cancer" [Radiother. Oncol. 213 (20… Co-author DOI 10.1016/j.radonc.2026.111681↗
  2. Long-Term outcomes of ablative stereotactic body radiation therapy for inoperable, non-metastatic pancreatic cancer. Co-author DOI 10.1016/j.radonc.2025.111210↗
  3. Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer. Co-author DOI 10.1186/s12885-025-13799-5↗
  4. A comprehensive multi-omics analysis uncovers the associations between gut microbiota and pancreatic cancer. First author DOI 10.3389/fmicb.2025.1592549↗
  5. Survival benefits of radiotherapy in locally advanced unresectable and metastatic pancreatic cancer: a single-institution cohort and SEER database analysis. Co-author DOI 10.3389/fonc.2024.1473251↗
  6. Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer. Co-author DOI 10.3748/wjg.v30.i12.1739↗
  7. Survival Outcomes and Failure Patterns in Patients with Inoperable Non-Metastatic Pancreatic Cancer Treated with Definitive Radiotherapy. Co-author DOI 10.3390/cancers15082213↗
  8. Risk factors, prognostic predictors, and nomograms for pancreatic cancer patients with initially diagnosed synchronous liver metastasis. Co-author DOI 10.4251/wjgo.v15.i1.128↗
  9. Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.4251/wjgo.v15.i1.155↗
  10. Risk factors, prognostic predictors, and nomograms for liver metastasis in patients with pancreatic cancer: a population-based study. Co-author DOI 10.21203/rs.3.rs-1550766/v1↗
  11. Identify Prognostic Factors and Establish a Risk Stratification Model to Predict Cancer-Specific Survival for Patients with Pancreatic Cancer Liver Metastasis:… Co-author DOI 10.21203/rs.3.rs-855925/v1↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jing Wang · 8 shared papers, 2021–2026 · strength 2.14
  2. Letian Zhang · 8 shared papers, 2021–2025 · strength 1.94
  3. Lin Yang · 2 shared papers, 2024–2025 · strength 0.50
  4. Han Kwang Yang · 1 shared paper, 2025 · strength 0.37
  5. Jing Wang · 1 shared paper, 2025 · strength 0.37
  6. Wen Zhang · 1 shared paper, 2025 · strength 0.22
  7. Wenwei Yang · 1 shared paper, 2025 · strength 0.22
  8. Xiaoting Ma · 1 shared paper, 2025 · strength 0.22
  9. Kai Ou · 1 shared paper, 2025 · strength 0.22
  10. Jing Wang · 1 shared paper, 2022 · strength 0.20
  11. Qianqian Wang · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.